Thursday, September 19, 2019

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Interview with Shay Schnet,CEO and Director, Mark Krytiuk, President and Chairman of Nabis Holdings Inc. (CSE: $NAB.C) (OTC: $NABIF)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Interview with Shay Schnet,CEO and Director, Mark Krytiuk,  President and Chairman of Nabis Holdings Inc. (CSE: $NAB.C) (OTC: $NABIF)

Delta, Kelowna, BC –September 19, 2019 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,  release today’s edition of potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Good afternoon and welcome to another episode of "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts

In today’s podcast I interview Shay Schnet, the CEO and Director, as well as Mark Krytiuk, the President and Chairman of the Board of Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF), where we discussed the importance of compliance and EU GMP facilities in the U.S. market as well as the cannabis industry as a whole.

Shay has over 20 years of business experience and was most recently a founding partner and Vice President of Operations at MPX Bioceutical Corporation. Shay spent the last 5 years of his career focused on the North American cannabis space and helped to build MPX’s portfolio of international cannabis assets.

Mark is a successful cannabis operator and was a founding partner of MPX. Mark has over 5 years of experience as the Vice President of Grow Operations for MPX overseeing the production of medical marijuana and pharma-grade products across North America.Mark has been directly involved in the rapid expansion and growth of nine facilities in three different countries, with budgets up to $30 million.

Both made their names known in the industry as the co-founders of MPX Bioceutical, one of the largest takeover offers in U.S. Cannabis to date with the MPX merger with iAnthus for $835M CAD.

When asked about the importance of vertical integration in the U.S. markets, Mark commented, “there’s a reason for it, especially in the U.S. You can’t cross state lines, or import cannabis or export cannabis, so you have to be able to control everything in that manufacturing process. There are certain states where there is an abundance of cultivation, and we are able to team up with cultivators and purchase their product at set rates. You’ll see that in Washington, California and Oregan where there’s an abundance of cultivation. Our beliefs are always based around GMP quality and standards and to be able to bring it to a higher standard than what you currently see in the U.S. Canada, even though the number of SKUs that are allowed to be released are very limited, they have set the bar very high with very high standards. If you see what’s happening in Europe, you have to be EU GMP. Unfortunately, the U.S. has not caught up to GMP, or almost pharma grade standards.”

When asked about the companies focus on the U.S. market and how this compared to other international markets coming online Mark commented, “It is the world’s largest market. I think all of Australia has about 5,000 patients, compared to just the state of  Michigan which has over 350,000 patients. We still have a strong belief that not only is the U.S. market the largest in the world, but it still has huge upside potential. It’s still a market where you can’t cross state lines and you don’t have federal banking, so there’s still a lot of changes coming to the market. By us thinking that the standard will come up to be GMP, and everyone will have to come to that standard at some time, for us we can just go to work immediately.”

Adding on to that and discussing what makes Nabis stand out in this market, Shay commented, “What we’re doing different is the GMP. You’re not seeing a lot of the MSO’s really looking at it. By doing GMP right off the bat, we are helping create the standards and staying above the regulations, knowing they’re coming. We really looked at California for inspiration. As soon as they introduced proper regulations into the market you had about 70% of the products drop off immediately. Right now you’re just seeing some of the bigger brands come back online, and some of them died off completely and some survived. We know that that’s going to carry across the nation and we’re just staying ahead of the curve.”

When discussing potential federal legalization in the U.S. and how this may affect the U.S. cannabis market, Shay commented, “It’s not a beneficial factor (for MSOs) at this point for federal legalization. Even when legalization comes in, there will still be some State laws. I think you’re a long away from where California will allow Washignton product to come in. I think federal legalization won’t really solve too much at this point. As it becomes more real you’ll have to focus on the branding and the products.”

Shay added, “I would definitely agree with what Shay just said. If you’re a cultivator in Washington and now someone can show up and build a million square foot mega facility, you’re going to be hard pressed to be able to compete for price at that point. In saying that we don’t build huge mega facilities, we build small micro GMP facilities. I would also agree with the fact that whether it’s federally legal or not, the state will not allow their license to be able to import from another state. The revenues and the jobs are going to be kept in that state because you still need to cultivate, process and retail it in that state.”

Nabis Holdings Inc. has been active in the last month having announced the  acquisition of a cultivation, production and fulfillment facility located in Camp Verde, Arizona near Phoenix, making this the second announced acquisition for Nabis in the state of Arizona following its definitive agreement to acquire a licensed medical marijuana business including a Phoenix dispensary.

The company also launched BIS (Be In Synergy), its new exclusive brand of cannabidiol (“CBD”) product lines as well as announced entering into a strategic agreement with CannaKorp, Inc. (“CannaKorp”), a Massachusetts-based technology start-up company that is simplifying and improving the experience for herbal vaporization, to be an authorized partner manufacturing and supplying Wisp Pods to be used in CannaKorp’s innovative Wisp Vaporizing System (“Wisp”) in the state of Arizona. The Company will supply custom Wisp Pods branded as BIS, the Company’s recently launched cannabidiol (“CBD”) brand.

To find out more information on Nabis Holdings Inc. visit their website here.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Subscribe to the new cannabis podcast series:

To hear more podcasts visit: podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and
Global investors must adhere to regulations of each country. Please read privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Follow us on Social Media



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

No comments:

Post a Comment